The effect of lamotrigine on valproic acid concentrations. 2011

Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital for Children, Perth, Western Australia.

OBJECTIVE To determine whether lamotrigine affects serum concentrations of valproic acid. METHODS Pre-morning-dose serum valproic acid concentrations were measured in 76 subjects with epilepsy (48 M, 28 F, age range 6-20 years, mean age 14 years) in whom lamotrigine was added while the dose of valproate and other medication remained unchanged. In a comparison group, either acetazolamide or gabapentin was added to sodium valproate. RESULTS Far more subjects (26/76 = 34%) had an increase of >25% in valproic acid concentration with lamotrigine than those who had a decrease of >25% (4/76 = 5.3%). The mean valproic acid concentration before starting lamotrigine was 61.0 mg/L and on lamotrigine was 67.1 mg/L; the difference in means was 6.1 mg/L (standard error 2.1, 95% confidence limits 2.0, 10.2, p=0.004, highly significant, paired sample t-test, two-tailed), a rise of 10%. The change in valproic acid concentration appeared to depend on the initial valproic acid concentration (Pearson r=-0.405, p<0.001). In 14.5% of the subjects the increase in valproate concentration was >50%, which could lead to toxicity, although the increase tended to occur with lower or intermediate initial valproic acid concentrations whereas a small overall decrease in valproic acid concentrations with lamotrigine was found with the higher initial valproic acid concentrations. One subject had abnormal bruising with the increased valproate level after lamotrigine was added, which resolved on decreasing the valproate dose. The changes in valproic acid concentrations in the comparison group were small (mean increase 2.6%) and were not statistically significant. CONCLUSIONS Although there is a wide variation in the changes of valproic acid concentrations when lamotrigine is added, the concentrations tend to increase rather than decrease, especially with low or intermediate initial valproic acid concentrations. In some cases valproate toxicity, manifested by abnormal bruising, may result, although at higher initial valproic acid concentrations the valproic acid concentration usually tends to fall slightly with the addition of lamotrigine.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077213 Lamotrigine A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER. 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine,3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine,BW-430C,Crisomet,Labileno,Lamictal,Lamiktal,BW 430C,BW430C
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
June 2004, The American journal of psychiatry,
Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
December 2009, The Annals of pharmacotherapy,
Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
June 2006, Drug metabolism and disposition: the biological fate of chemicals,
Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
October 2015, Naunyn-Schmiedeberg's archives of pharmacology,
Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
October 2008, Progress in neuro-psychopharmacology & biological psychiatry,
Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
June 2016, Therapeutic drug monitoring,
Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
April 2009, Journal of neural transmission (Vienna, Austria : 1996),
Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
January 2004, Epilepsy currents,
Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
April 1998, Pediatric neurology,
Andrew C Martin, and Frank M C Besag, and David J Berry, and Frank P Besag
January 1997, Epilepsy research,
Copied contents to your clipboard!